Stuart H. Johnston

2.4k total citations · 1 hit paper
17 papers, 1.8k citations indexed

About

Stuart H. Johnston is a scholar working on Molecular Biology, Epidemiology and Computational Theory and Mathematics. According to data from OpenAlex, Stuart H. Johnston has authored 17 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Computational Theory and Mathematics. Recurrent topics in Stuart H. Johnston's work include Melanoma and MAPK Pathways (6 papers), Computational Drug Discovery Methods (4 papers) and Developmental Biology and Gene Regulation (4 papers). Stuart H. Johnston is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), Computational Drug Discovery Methods (4 papers) and Developmental Biology and Gene Regulation (4 papers). Stuart H. Johnston collaborates with scholars based in United States, United Kingdom and Canada. Stuart H. Johnston's co-authors include Thomas Vogt, Richa Wilson, Kenneth D. Irvine, Jihua Chen, Yang Wang, Vladislav M. Panin, Daniel J. Moloney, Pamela Stanley, Robert S. Haltiwanger and Shao Li and has published in prestigious journals such as Nature, Nature Cell Biology and Development.

In The Last Decade

Stuart H. Johnston

17 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fringe is a glycosyltransferase that modifies Notch

2000 695 citations Daniel J. Moloney, Vladislav M. Panin et al. Nature profile →

Peers

Stuart H. Johnston

ONCOL

IMMUN

GENET

Stephen Gschmeissner United Kingdom

Wendy R. Gordon United States

Neetu Gupta France

Beishan Liu United States

Marc Fiedler United Kingdom

Alessandro Cuomo Italy

Damaris Bausch‐Fluck Switzerland

Ernie de Boer Netherlands

Nenad Tomas̆ević United States

Ari J. Firestone United States

Stephen Gschmeissner United Kingdom

Stuart H. Johnston

924 ×0.6

124 ×0.6

ONCOL

262 ×1.3

IMMUN

125 ×0.6

GENET

216 ×1.1

Citations per year, relative to Stuart H. Johnston Stuart H. Johnston (= 1×) peers Stephen Gschmeissner

Countries citing papers authored by Stuart H. Johnston

Since Specialization

Citations

This map shows the geographic impact of Stuart H. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart H. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart H. Johnston more than expected).

Fields of papers citing papers by Stuart H. Johnston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart H. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart H. Johnston. The network helps show where Stuart H. Johnston may publish in the future.

Co-authorship network of co-authors of Stuart H. Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart H. Johnston. A scholar is included among the top collaborators of Stuart H. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart H. Johnston. Stuart H. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Rosen, Lee S., Patricia LoRusso, Wen Wee, et al.. (2016). A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors. Investigational New Drugs. 34(5). 604–613. 62 indexed citations

Dickson, Mark A., Michael S. Gordon, Gerald M. Edelman, et al.. (2014). Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumors. Investigational New Drugs. 33(2). 349–356. 23 indexed citations

Choo, Edna F., Marcia Belvin, Jason Boggs, et al.. (2012). Preclinical Disposition of GDC-0973 and Prospective and Retrospective Analysis of Human Dose and Efficacy Predictions. Drug Metabolism and Disposition. 40(5). 919–927. 28 indexed citations

Davies, A., Michelle Reid, Stephen J. Hadfield, et al.. (2012). Identification of Clinical Isolates of α-Hemolytic Streptococci by 16S rRNA Gene Sequencing, Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Using MALDI Biotyper, and Conventional Phenotypic Methods: a Comparison. Journal of Clinical Microbiology. 50(12). 4087–4090. 31 indexed citations

Hoeflich, Klaus P., Mark Merchant, Christine Orr, et al.. (2011). Intermittent Administration of MEK Inhibitor GDC-0973 plus PI3K Inhibitor GDC-0941 Triggers Robust Apoptosis and Tumor Growth Inhibition. Cancer Research. 72(1). 210–219. 200 indexed citations

Rosen, Lee S., Patricia LoRusso, Wen Wee, et al.. (2011). Abstract 4716: A first-in-human phase 1 study to evaluate the MEK1/2 inhibitor GDC-0973 administered daily in patients with advanced solid tumors. Cancer Research. 71(8_Supplement). 4716–4716. 18 indexed citations

Harris, Llinos G., Stuart H. Johnston, Lars Frommelt, et al.. (2010). Rapid Identification of Staphylococci from Prosthetic Joint Infections Using MALDI-TOF Mass-Spectrometry. The International Journal of Artificial Organs. 33(9). 568–574. 53 indexed citations

Johnston, Stuart H.. (2007). XL518, a potent selective orally bioavailable MEK1 inhibitor, downregulates the RAS/RAF/MEK/ERK pathway in vivo, resulting in tumor growth inhibition and regression in pre-clinical models. Molecular Cancer Therapeutics. 6. 11 indexed citations

Cole, Susan E., et al.. (2001). Identification, expression analysis, and mapping of B3galt6, a putative galactosyl transferase gene with similarity to Drosophila brainiac. Mammalian Genome. 12(2). 177–179. 9 indexed citations

10.

Moloney, Daniel J., Vladislav M. Panin, Stuart H. Johnston, et al.. (2000). Fringe is a glycosyltransferase that modifies Notch. Nature. 406(6794). 369–375. 695 indexed citations breakdown →

11.

Hicks, Carol, et al.. (2000). Fringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2. Nature Cell Biology. 2(8). 515–520. 327 indexed citations

12.

Moran, Jennifer L., Stuart H. Johnston, Cordelia Rauskolb, et al.. (1999). Genomic structure, mapping, and expression analysis of the mammalian Lunatic, Manic, and Radical fringe genes. Mammalian Genome. 10(6). 535–541. 19 indexed citations

13.

Johnston, Stuart H., et al.. (1997). A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. Development. 124(11). 2245–2254. 259 indexed citations

14.

Baum, Ellen Z., Stuart H. Johnston, Geraldine Bebernitz, & Yakov Gluzman. (1996). Development of a Scintillation Proximity Assay for Human Cytomegalovirus Protease Using33Phosphorous. Analytical Biochemistry. 237(1). 129–134. 13 indexed citations

15.

Baum, Ellen Z., Marshall M. Siegel, Geraldine Bebernitz, et al.. (1996). Inhibition of Human Cytomegalovirus UL80 Protease by Specific Intramolecular Disulfide Bond Formation. Biochemistry. 35(18). 5838–5846. 20 indexed citations

16.

Jones, Thomas R., et al.. (1994). Proteolytic activity of human cytomegalovirus UL80 protease cleavage site mutants. Journal of Virology. 68(6). 3742–3752. 42 indexed citations

17.

Chae, Kun, Stuart H. Johnston, & Kenneth S. Korach. (1991). Multiple estrogen binding sites in the uterus: Stereochemistry of receptor and non-receptor binding of diethylstilbestrol and its metabolites. The Journal of Steroid Biochemistry and Molecular Biology. 38(1). 35–42. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact